ANDA 212945, held by Amneal Eu Ltd. Vasopressin.
As of Nov 15, 2026, ANDA 212945 (Vasopressin), held by Amneal Eu Ltd, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 10, 2022 | Original application | Tentative approval |
| Product | Active ingredient | Marketing |
|---|---|---|
| Vasopressin200UNITS/10ML(20UNITS/ML) ยท injectable;injection | Vasopressin | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters